Figure 2: Increase expression of HES1 in cisplatin based chemotherapeautic HNSCC. | Scientific Reports

Figure 2: Increase expression of HES1 in cisplatin based chemotherapeautic HNSCC.

From: NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell

Figure 2

(A) Representative hematoxylin-eosin and immunohistochemical staining of HES1in HNSCC patient receiving TPF neoadjuvant chemotherapy with quantitative histoscore in (B) Scale bar, 50 μm. (C) Representative immunohistochemical staining of HES1 with quantitative histoscore Representative hematoxylin-eosin and immunohistochemical staining of HES1in HNSCC patient receiving TPF neoadjuvant chemotherapy with quantitative histoscore in (D). Each sample score present as a dot, paired t test, *P < 0.05; ***P < 0.001.

Back to article page